The Brazilian vaccine manufacturers' perspective and its current status

Biologicals

Volumn 37, Issue 3, 2009, Pages 173-176

  Homma, Akira ^a  

^a Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Biotechnology; Health; Innovation; Vaccine manufacture

Indexed keywords

MEASLES VACCINE; POLIOMYELITIS VACCINE; VACCINE;

ARTICLE; BIOLOGICAL THERAPY; BRAZIL; DEVELOPING COUNTRY; DRUG MANUFACTURE; HEALTH CARE POLICY; IMMUNOBIOLOGY; INVESTMENT; NONHUMAN; PRIORITY JOURNAL; VACCINE PRODUCTION;

BRAZIL; HUMANS; INDUSTRY; VACCINES;

EID: 65649094466     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.02.011     Document Type: Article

References (7)

1. Biominas Foundation; 2007.
2. Immunobiological Technology Institute/Oswaldo Cruz Foundation; 2008.
3. Azevedo N, Gadelha CAG, Ponte CF, Trindade C, Hamilton W. Inovação em saúde: dilemas e desafios de uma instituição pública. In: Fiocruz, editor; 2007.
4. Buss PM, Temporão JG, Carvalheiro JR. Vacinas, soros e imunizações no Brasil. In: Fiocruz, editor; 2005.
5. Homma A, Martins RM, Jessouroum E, Oliva O. Technological development: a weak link in vaccine innovation in Brazil. História, Ciências, Saúde Manguinhos 2003;10(2). In: Fiocruz, editor. Imunização no Brasil. apud.
6. Statistics and Geography Brazilian Institute (IBGE).
7. Brazilian Ministry of Health, SI-PNI; 2008.